Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05858944

Home Blood Pressure Intervention in the Community Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10,000 (estimated)
Sponsor
Shanghai Institute of Hypertension · Academic / Other
Sex
All
Age
60 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of the study is to explore whether a lower home blood pressure target (125/75 v.s. 135/85 mmHg) would be beneficial to elderly treated hypertensive patients in terms of reduced incidence of cardiovascular events. The study also aims to promote the application of standardised and information-based home blood pressure monitoring in community hypertension management.

Conditions

Interventions

TypeNameDescription
DRUGIntensive Home BP controlIf the target home BP level is not achieved during the follow-up periods, type and dosage of antihypertensive drugs will be adjusted according to current guidelines and physician's clinical experience.
DRUGStandard Home BP controlIf the target home BP level is not achieved during the follow-up periods, type and dosage of antihypertensive drugs will be adjusted according to current guidelines and physician's clinical experience.

Timeline

Start date
2023-05-06
Primary completion
2029-12-31
Completion
2030-06-30
First posted
2023-05-15
Last updated
2025-01-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05858944. Inclusion in this directory is not an endorsement.

Home Blood Pressure Intervention in the Community Trial (NCT05858944) · Clinical Trials Directory